A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Conditions:   Cutaneous Melanoma;   Non-small Cell Lung Cancer;   Colorectal Neoplasms;   Pancreatic Neoplasms;   Mesothelioma Intervention:   Drug: SGN-BB228 Sponsor:   Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2022 Category: Research Source Type: clinical trials